Aims to resolve patient diagnostic odyssey, often spanning years and multiple misdiagnoses before accurate diagnosis Combines cutting-edge technology and streamlined CE-IVD bioinformatics pipeline ...
CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally
Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic testing ...
The Druzhba pipeline carrying Russian oil through Ukraine to Hungary and Slovakia may have been fixed after recent damage but Ukraine may be holding up restarting supplies to pressure Hungary to drop ...
CENTOGENE has opened an expanded sampling area, next to the existing Walk-In COVID-19 Testing Facility, allowing significant increases in COVID-19 testing sampling capacity Innovative digital ...
RIYADH, Saudi Arabia, July 2, 2023 /PRNewswire/ -- CENTOGENE N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical ...
Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson's Disease (ROPAD) Study aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results